| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |